BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 660732)

  • 1. Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from A1 and B disease.
    Golimbu M; Schinella R; Morales P; Kurusu S
    J Urol; 1978 May; 119(5):618-22. PubMed ID: 660732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer.
    Petros JA; Catalona WJ
    J Urol; 1992 Jun; 147(6):1574-5. PubMed ID: 1593688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage A2 prostatic carcinoma: should staging system be reclassified?
    Golimbu M; Morales P
    Urology; 1979 Jun; 13(6):592-6. PubMed ID: 452192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients.
    Smith JA; Seaman JP; Gleidman JB; Middleton RG
    J Urol; 1983 Aug; 130(2):290-2. PubMed ID: 6876275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer.
    Fowler JE; Whitmore WF
    Cancer; 1981 Jun; 47(12):2941-5. PubMed ID: 7260881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic carcinoma. Influence of tumor grade on results of pelvic lymphadenectomy.
    Donohue RE; Fauver HE; Whitesel JA; Augspurger RR; Pfister RR
    Urology; 1981 May; 17(5):435-40. PubMed ID: 7233656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic lymphadenectomy in stage A prostatic cancer.
    Donohue RE; Pfister RR; Weigel JW; Stonington OG
    Urology; 1977 Mar; 9(3):273-5. PubMed ID: 841802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of unsuspected regional lymph node metastases in prostatic adenocarcinoma.
    Saltzstein SL; McLaughlin AP
    Cancer; 1977 Sep; 40(3):1212-21. PubMed ID: 902239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Staging pelvic lymphadenectomy for carcinoma of the prostate].
    Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K
    Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases.
    McLaughlin AP; Saltzstein SL; McCullough DL; Gittes RF
    J Urol; 1976 Jan; 115(1):89-94. PubMed ID: 1246119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of lymph node involvement in localized carcinoma of the prostate.
    Reddy EK; Mebust WK; Weigel JW; Giri S; Mansfield CM
    J Natl Med Assoc; 1984 May; 76(5):463-6. PubMed ID: 6737503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary?
    Freiha FS; Pistenma DA; Bagshaw MA
    J Urol; 1979 Aug; 122(2):176-7. PubMed ID: 459009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
    Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
    Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of incidental prostatic carcinoma].
    Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
    Hinyokika Kiyo; 1991 Feb; 37(2):135-9. PubMed ID: 2048491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer.
    Middleton RG
    NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of staging pelvic lymphadenectomy for prostatic cancer.
    Fujioka T; Koike H; Aoki H; Ohhori T; Chiba R; Okamoto S
    Urol Int; 1987; 42(5):380-4. PubMed ID: 3433586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in localized prostatic carcinoma.
    Pontes JE; Wajsman Z; Huben RP; Wolf RM; Englander LS
    J Urol; 1985 Dec; 134(6):1137-9. PubMed ID: 4057404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical prostatectomy for stage B2 prostatic cancer.
    Middleton RG; Smith JA
    J Urol; 1982 Apr; 127(4):702-3. PubMed ID: 7069834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival.
    Fowler JE; Mills SE
    J Urol; 1985 Jan; 133(1):49-52. PubMed ID: 3964879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer of the prostate: results of radiotherapy. Multicenter study].
    Allain YM; Bolla M; Douchez J; Gary-Bobo J; Geslin J; Huart J; Mathieu G; Mazeron JJ
    Bull Cancer; 1985; 72(6):559-67. PubMed ID: 3912017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.